Olaratumab Plus Doxorubicin in Advanced Soft Tissue Sarcoma

2 Views

07/18/23

William D. Tap, MD, chief, Sarcoma Medical Oncology Service, Memorial Sloan Kettering Cancer Center, discusses results from a phase Ib/II presented at the 2015 Connective Tissue Oncology Society (CTOS) Annual Meeting.

For more resources and information regarding anticancer targeted therapies: http://targetedonc.com/